Endpoint | Cohort A | Cohort B | p value |
Median OS | 31 months | NR | p = 0.363 |
Alive at 24 months | 57.4% | 63.5% |
|
Alive at 36 months | 38.3% | 59.0% |
|
Median PFS | 8 months | 16 months | p = 0.368 |
no disease progression at 24 months | 0 | 49.3% |
|
no disease progression at 36 months | 0 | 22.4% |
|